Inhibition of HIV infectivity by human saliva

Oral Diseases

Volumn 3, Issue SUPPL. 1, 1997, Pages

  Malamud, D ^a   Nagashunmugam, T ^b   Davis, C ^a   Kennedy, S ^a   Abrams, W R ^a   Kream, R ^b   Friedman, H M ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

HIV; Saliva; Submandibular gland

Indexed keywords

ANTIGEN P24; BETA GALACTOSIDASE; CD4 ANTIGEN;

CONFERENCE PAPER; CONTROLLED STUDY; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MONONUCLEAR CELL; PRIORITY JOURNAL; RETROVIRUS; SALIVA ANALYSIS; SUBMANDIBULAR GLAND; VIRUS CELL INTERACTION; VIRUS INFECTIVITY;

EID: 0030965204     PISSN: 1354523X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1601-0825.1997.tb00376.x     Document Type: Conference Paper

References (19)

1. Archibald DW, Cole GA (1990). In vitro inhibition of HIV-1 infectivity by human salivas. AIDS Res Hum Retroviruses 6: 1425-1432.
2. Archibald DW, Hebert CA, Gregory KL et al (1993). Effects of human salivas on recombinant HIV-1 proteins. Crit Rev Oral Biol Med 4: 475-478.
3. Bergey EJ, Cho MI, Hammarskjold ML et al (1993). Aggregation of human immunodeficiency virus type 1 by human salivary secretions. Crit Rev Oral Biol Med 4: 467-474.
4. Bergey EJ, Cho MI, Blumberg BM et al (1994). Interaction of HIV-1 and human salivary mucins. J Acquir Immune Defic Syndr 7: 995-1002.
5. Fox PC, Wolff A, Yeh CK et al (1988). Saliva inhibits HIV-1 infectivity. J Am Dent Assoc 116: 635-637.
6. Fox PC, Wolff A, Yeh CK et al (1989). Salivary inhibition of HIV-1 infectivity: functional properties and distribution in men, women, and children. J Am Dent Assoc 118: 709-711.
7. Fultz PN (1986). Components of saliva inactivate human immunodeficiency virus [letter]. Lancet 2: 1215.
8. Graham FW, van der Eb AJ (1973). A technique for assay of infectivity of human adenovirus DNA. Virology 52: 456-467.
9. Kimpton J, Emerman M (1992). Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated β-galactosidase gene. J Virol 66: 2232-2239.
10. Malamud D, Davis C, Berthold P et al (1993). Human submandibular saliva aggregates HIV. AIDS Res Hum Retroviruses 9: 633-637.
11. Malamud D, Friedman HM (1993). HIV in the oral cavity: virus, viral inhibitory activity, and antiviral antibodies. Crit Rev Oral Biol Med 4: 461-466.
12. McNeeley TB, Dealy M, Dripps D et al (1995). Secretory Leukocyte Protease Inhibitor: A human saliva protein exhibiting antihuman immunodeficiency virus 1 activity in-vitro. J Clin Inves 96: 456-464.
13. Moore JP, McKeating JA, Huang YX et al (1992). Virions of primary human immunodeficiency virus type 1 isolates resistant to sCD4 neutralization differ in sCD4 binding and glycoprotein gp120 retention from sCD4-sensitive isolates. J Virol 66: 235-243.
14. Moore JP, Cao Y, Qing L et al (1995). Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120. J Virol 69: 101-109.
15. Nagashunmugam T, Friedman HM, Sundaresan C et al (1996). Anti-viral activity of human submandibular saliva is specific to HIV-1. 3rd Conference on Retroviruses and Opportunistic Infections Washington DC, p 134.
16. Robinovitch MR, Iversen JM, Resnick L (1993). Anti-infectivity activity of human salivary secretions toward human immunodeficiency virus. Crit Rev Oral Biol Med 4: 455-459.
17. Robinovitch MR, Ashley RL, Iverson JM et al (1996). Measurement of salivary inhibition of HIV-1 utilizing the MAGI assay. J Dent Res 75: 310.
18. Strebel K, Daugherty D, Clouse D et al (1987) HIV-1 'A' (sor gene product) is essential for virus infectivity. Nature 328: 728-730.
19. Yeh CK, Handelman B, Fox PC et al (1992). Further studies of salivary inhibition of HIV-1 infectivity. J Acquir Immune Defic Syndr 5: 898-903.